NCT00869986 - A Study for Patients With Relapsing Remitting Multiple Sclerosis | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG

dirucotide

500mg, intravenous, every 6 months for 15 months

DRUG

placebo

intravenous, once every six months for 15 months

Trial Locations (6)

Military Medical Academy, Sofia

Silesian Medical School, Katowice

Clinical City Hospital No. 11, Moscow

Clinical Center of Serbia, Belgrade

FNsP J A Reimana, Prešov

Vinnitsa State Medical University, Vinnitsa